Peter D. Aplan

8.9k total citations
155 papers, 6.4k citations indexed

About

Peter D. Aplan is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Peter D. Aplan has authored 155 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Molecular Biology, 79 papers in Hematology and 46 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Peter D. Aplan's work include Acute Myeloid Leukemia Research (65 papers), Acute Lymphoblastic Leukemia research (46 papers) and Chronic Lymphocytic Leukemia Research (19 papers). Peter D. Aplan is often cited by papers focused on Acute Myeloid Leukemia Research (65 papers), Acute Lymphoblastic Leukemia research (46 papers) and Chronic Lymphocytic Leukemia Research (19 papers). Peter D. Aplan collaborates with scholars based in United States, Australia and Canada. Peter D. Aplan's co-authors include Ilan R. Kirsch, Christopher Slape, Sheryl M. Gough, David S. Chervinsky, Donald P. Lombardi, Trang Hoang, Sabine Herblot, C. Glenn Begley, Zhenhua Zhang and Xianfeng Zhao and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Peter D. Aplan

147 papers receiving 6.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter D. Aplan United States	48	4.4k	2.3k	1.2k	1.1k	899	155	6.4k
John D. Crispino United States	52	5.0k 1.1×	3.2k 1.4×	906 0.7×	985 0.9×	698 0.8×	168	8.1k
Toshiya Inaba Japan	37	2.6k 0.6×	1.7k 0.7×	605 0.5×	653 0.6×	799 0.9×	124	4.6k
Joop H. Jansen Netherlands	41	4.4k 1.0×	2.9k 1.3×	530 0.4×	1.4k 1.3×	1.1k 1.2×	155	7.0k
Stefan K. Bohlander Germany	52	5.4k 1.2×	4.2k 1.9×	1.5k 1.2×	934 0.9×	1.6k 1.8×	184	9.2k
Marieke von Lindern Netherlands	43	3.9k 0.9×	1.4k 0.6×	398 0.3×	618 0.6×	633 0.7×	134	5.7k
Alan J. Warren United Kingdom	34	3.8k 0.9×	1.9k 0.8×	369 0.3×	910 0.9×	660 0.7×	61	5.5k
Takaomi Sanda Singapore	35	3.1k 0.7×	916 0.4×	705 0.6×	767 0.7×	1.0k 1.2×	108	4.5k
Martin A. Horstmann Germany	31	2.2k 0.5×	1.6k 0.7×	1.7k 1.4×	675 0.6×	914 1.0×	90	4.9k
James C. Mulloy United States	41	4.0k 0.9×	2.5k 1.1×	262 0.2×	2.0k 1.8×	1.3k 1.4×	114	6.7k
Christopher J. Hetherington United States	29	2.8k 0.6×	2.1k 0.9×	324 0.3×	1.8k 1.7×	817 0.9×	32	4.8k

Countries citing papers authored by Peter D. Aplan

Since Specialization

Citations

This map shows the geographic impact of Peter D. Aplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Aplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Aplan more than expected).

Fields of papers citing papers by Peter D. Aplan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter D. Aplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Aplan. The network helps show where Peter D. Aplan may publish in the future.

Co-authorship network of co-authors of Peter D. Aplan

This figure shows the co-authorship network connecting the top 25 collaborators of Peter D. Aplan. A scholar is included among the top collaborators of Peter D. Aplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter D. Aplan. Peter D. Aplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Ganqian, Qian Lai, Huacheng Luo, et al.. (2025). HoxBlinc lncRNA reprograms CTCF-independent TADs to drive leukemic transcription and HSC dysregulation in NUP98-rearranged leukemia. Journal of Clinical Investigation. 135(7). 2 indexed citations

Cao, Dengchao, et al.. (2025). 5-Azacytidine and decitabine induce C > G transversions in both murine and human cells. Leukemia. 39(9). 2112–2124.

Schulz, Eduard, Peter D. Aplan, Sylvie Freeman, & Steven Z. Pavletic. (2023). Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes. Blood Advances. 7(16). 4381–4394. 7 indexed citations

Goldberg, Liat, Yang Jo Chung, Masahiro Onozawa, et al.. (2021). Mutant Idh2 Cooperates with a NUP98-HOXD13 Fusion to Induce Early Immature Thymocyte Precursor ALL. Cancer Research. 81(19). 5033–5046. 8 indexed citations

Chung, Yang Jo, et al.. (2018). Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome. Journal of Visualized Experiments.

Gough, Sheryl M., Fan Lee, Fan Yang, et al.. (2014). NUP98–PHF23 Is a Chromatin-Modifying Oncoprotein That Causes a Wide Array of Leukemias Sensitive to Inhibition of PHD Histone Reader Function. Cancer Discovery. 4(5). 564–577. 59 indexed citations

Gough, Sheryl M., Yang Jo Chung, & Peter D. Aplan. (2012). Depletion of Cytotoxic T-Cells Does Not Protect NUP98-HOXD13 Mice from Myelodysplastic Syndrome but Reveals a Modest Tumor Immunosurveillance Effect. PLoS ONE. 7(5). e36876–e36876. 6 indexed citations

Lowe, Linda A., et al.. (2010). Enforced Expression of Simian Virus 40 Large T-Antigen Leads to Testicular Germ Cell Tumors in Zebrafish. Zebrafish. 7(4). 333–341. 20 indexed citations

Hillion, Jöelle, Surajit Dhara, Takita Felder Sumter, et al.. (2008). The High-Mobility Group A1a/Signal Transducer and Activator of Transcription-3 Axis: An Achilles Heel for Hematopoietic Malignancies?. Cancer Research. 68(24). 10121–10127. 87 indexed citations

10.

Caudell, David L., Zhenhua Zhang, Yang Jo Chung, & Peter D. Aplan. (2007). Expression of a CALM-AF10 Fusion Gene Leads to Hoxa Cluster Overexpression and Acute Leukemia in Transgenic Mice. Cancer Research. 67(17). 8022–8031. 52 indexed citations

11.

Slape, Christopher, Helge Hartung, Ying‐Wei Lin, et al.. (2007). Retroviral Insertional Mutagenesis Identifies Genes that Collaborate with NUP98-HOXD13 during Leukemic Transformation. Cancer Research. 67(11). 5148–5155. 54 indexed citations

12.

Slape, Christopher, Lino Tessarollo, & Peter D. Aplan. (2006). Generation of immortal, IL3-dependent cell lines from embryonic stem (ES) cells expressing a NUP98-HOXD13 fusion gene. Cancer Research. 66. 61–61. 1 indexed citations

13.

Lin, Ying-Wei, Mary Barbara, Norman N. Iscove, et al.. (2005). OLIG2 (BHLHB1), a bHLH Transcription Factor, Contributes to Leukemogenesis in Concert with LMO1. Cancer Research. 65(16). 7151–7158. 26 indexed citations

14.

Aplan, Peter D., et al.. (2004). NUP98-Topoisomerase 1 acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation. Blood. 104(4). 1127–1136. 1 indexed citations

15.

Levantini, Elena, Alessandra Giorgetti, Francesco Cerisoli, et al.. (2003). Unsuspected role of the brain morphogenetic geneOtx1in hematopoiesis. Proceedings of the National Academy of Sciences. 100(18). 10299–10303. 8 indexed citations

16.

Zhao, Xianfeng & Peter D. Aplan. (1998). SCL binds the human homologue of DRG in vivo1The DRG cDNA sequence has been deposited in GenBank under accession number AF078103.1. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1448(1). 109–114. 21 indexed citations

17.

Aplan, Peter D., Craig A. Jones, David S. Chervinsky, et al.. (1997). An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. The EMBO Journal. 16(9). 2408–2419. 117 indexed citations

18.

Stanulla, Martin, et al.. (1997). Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus. Leukemia. 11(4). 490–496. 59 indexed citations

19.

Aplan, Peter D., S Raimondi, & Ilan R. Kirsch. (1992). Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia.. The Journal of Experimental Medicine. 176(5). 1303–1310. 51 indexed citations

20.

Aplan, Peter D., Kenneth Nakahara, Stuart H. Orkin, & Ilan R. Kirsch. (1992). The SCL gene product: a positive regulator of erythroid differentiation.. The EMBO Journal. 11(11). 4073–4081. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact